John A. Armitstead

637 total citations
38 papers, 434 citations indexed

About

John A. Armitstead is a scholar working on Geriatrics and Gerontology, Emergency Medical Services and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John A. Armitstead has authored 38 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Geriatrics and Gerontology, 12 papers in Emergency Medical Services and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John A. Armitstead's work include Pharmaceutical Practices and Patient Outcomes (21 papers), Patient Safety and Medication Errors (11 papers) and Innovations in Medical Education (8 papers). John A. Armitstead is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (21 papers), Patient Safety and Medication Errors (11 papers) and Innovations in Medical Education (8 papers). John A. Armitstead collaborates with scholars based in United States and China. John A. Armitstead's co-authors include Kyle A. Weant, Marianne F. Ivey, Kelly M. Smith, George A. Davis, Aaron M. Cook, Alim Ladha, Deanna Sasaki‐Adams, Eldad Hadar, Matthew G. Ewend and Martin E. Evans and has published in prestigious journals such as Neurosurgery, Transplantation and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

John A. Armitstead

35 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Armitstead United States 10 224 161 87 61 51 38 434
Dennis Grauer United States 12 191 0.9× 101 0.6× 50 0.6× 58 1.0× 66 1.3× 33 533
Cecilia M. Fernández-Llamazares Spain 16 214 1.0× 246 1.5× 176 2.0× 52 0.9× 49 1.0× 67 620
Christiane Eickhoff Germany 11 341 1.5× 93 0.6× 131 1.5× 95 1.6× 101 2.0× 24 573
Jane Portlock United Kingdom 13 234 1.0× 62 0.4× 48 0.6× 34 0.6× 161 3.2× 42 552
Eman A. Hammad Jordan 13 202 0.9× 80 0.5× 43 0.5× 72 1.2× 78 1.5× 33 449
Richard A. Hutchinson United States 10 340 1.5× 141 0.9× 138 1.6× 31 0.5× 104 2.0× 46 525
Judith Coombes Australia 8 198 0.9× 108 0.7× 31 0.4× 45 0.7× 103 2.0× 26 402
T.P.G.M. de Vries Netherlands 6 232 1.0× 79 0.5× 64 0.7× 79 1.3× 74 1.5× 7 457
R.P. Sequeira Bahrain 13 143 0.6× 46 0.3× 38 0.4× 78 1.3× 47 0.9× 26 347
Elaine Walsh Ireland 10 203 0.9× 104 0.6× 53 0.6× 17 0.3× 80 1.6× 35 422

Countries citing papers authored by John A. Armitstead

Since Specialization
Citations

This map shows the geographic impact of John A. Armitstead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Armitstead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Armitstead more than expected).

Fields of papers citing papers by John A. Armitstead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Armitstead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Armitstead. The network helps show where John A. Armitstead may publish in the future.

Co-authorship network of co-authors of John A. Armitstead

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Armitstead. A scholar is included among the top collaborators of John A. Armitstead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Armitstead. John A. Armitstead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turner, Suzanne D., et al.. (2024). Pharmacist perceptions of continuing professional development and goal development in a community health-system. Currents in Pharmacy Teaching and Learning. 16(12). 102166–102166. 1 indexed citations
2.
Haas, Curtis E., Lori T. Armistead, Craig J. Beavers, et al.. (2023). Comprehensive medication management: Review and recommendations for quality measures. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(4). 404–415. 3 indexed citations
3.
Armitstead, John A., et al.. (2023). Impact of acute-care pharmacy services on health system skilled nursing locations. 7. 13–13. 1 indexed citations
4.
Pardo, Joe & John A. Armitstead. (2014). New practitioner engagement in continuous professional development. American Journal of Health-System Pharmacy. 71(10). 788–789. 3 indexed citations
5.
Smith, Kelly M., et al.. (2012). Patterns of Pharmacist Continuing Education and Concordance with Practice Areas in an Academic Medical Center. Hospital Pharmacy. 47(8). 626–632. 1 indexed citations
6.
Weant, Kyle A. & John A. Armitstead. (2010). Emergency medicine pharmacy. American Journal of Health-System Pharmacy. 67(19). 1595–1597. 3 indexed citations
7.
Weant, Kyle A., John A. Armitstead, Alim Ladha, et al.. (2009). COST EFFECTIVENESS OF A CLINICAL PHARMACIST ON A NEUROSURGICAL TEAM. Neurosurgery. 65(5). 946–951. 48 indexed citations
8.
Macaulay, Tracy E., et al.. (2009). Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia. Journal of Oncology Pharmacy Practice. 16(3). 161–166. 8 indexed citations
9.
Smith, Kelly M., et al.. (2006). Internally-Developed Online Adverse Drug Reaction and Medication Error Reporting Systems. Hospital Pharmacy. 41(5). 428–436. 1 indexed citations
11.
Armitstead, John A., et al.. (2006). Enhanced pharmacy training for counter-terrorism and disaster response. Journal of Telemedicine and Telecare. 12(1_suppl). 3–5. 4 indexed citations
12.
Smith, Kelly M., et al.. (2005). Use of an Audience Response System to Introduce an Anticoagulation Guide to Physicians, Pharmacists, and Pharmacy Students. American Journal of Pharmaceutical Education. 69(2). 28–28. 8 indexed citations
13.
Smith, Kelly M., et al.. (2005). Use of an Audience Response System to Introduce an Anticoagulation Guide to Physicians, Pharmacists, and Pharmacy Students. American Journal of Pharmaceutical Education. 69(2). 28–28. 26 indexed citations
14.
Martin, Craig A., Ighovwerha Ofotokun, Robert P. Rapp, et al.. (2005). Results of an antimicrobial control program at a university hospital. American Journal of Health-System Pharmacy. 62(7). 732–738. 47 indexed citations
15.
Rapp, Robert P., et al.. (2004). Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital*. Current Medical Research and Opinion. 20(4). 469–476. 7 indexed citations
16.
Armitstead, John A., et al.. (2003). A Retrospective Evaluation of Vitamin K1 Therapy to Reverse the Anticoagulant Effect of Warfarin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(10). 1245–1250. 7 indexed citations
17.
Smith, Kelly M., et al.. (2003). Evolution and operation of a pharmacy residency on-call program. American Journal of Health-System Pharmacy. 60(21). 2236–2241. 22 indexed citations
18.
Armitstead, John A., et al.. (2001). Hospital and Pharmacy Departmental Policies and Procedures for Gene Therapy at a Teaching Institution. Hospital Pharmacy. 36(1). 56–66. 4 indexed citations
19.
Martin, Jill, Raymond Jang, Timothy Schroeder, et al.. (1998). Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation. Transplantation Proceedings. 30(8). 4082–4084. 8 indexed citations
20.
Ivey, Marianne F., John A. Armitstead, & Kiranpal S. Sangha. (1995). Critical pathways at University of Cincinnati Hospital. American Journal of Health-System Pharmacy. 52(10). 1053–1058. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026